WO2004112836A8 - Ophthalmic compositions containing a synergistic combination of two polymers - Google Patents

Ophthalmic compositions containing a synergistic combination of two polymers Download PDF

Info

Publication number
WO2004112836A8
WO2004112836A8 PCT/US2004/018068 US2004018068W WO2004112836A8 WO 2004112836 A8 WO2004112836 A8 WO 2004112836A8 US 2004018068 W US2004018068 W US 2004018068W WO 2004112836 A8 WO2004112836 A8 WO 2004112836A8
Authority
WO
WIPO (PCT)
Prior art keywords
polymers
compositions containing
ophthalmic compositions
synergistic combination
ophthalmic
Prior art date
Application number
PCT/US2004/018068
Other languages
French (fr)
Other versions
WO2004112836A2 (en
WO2004112836A3 (en
Inventor
Masood A. Chowhan
Huagang Chen
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33539082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2004112836(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to JP2006533590A priority Critical patent/JP4860475B2/en
Priority to AU2004249137A priority patent/AU2004249137B2/en
Priority to CA2527712A priority patent/CA2527712C/en
Priority to KR1020057023409A priority patent/KR101147046B1/en
Priority to KR1020117005797A priority patent/KR101131056B1/en
Priority to MXPA05013290A priority patent/MXPA05013290A/en
Priority to EP16153017.5A priority patent/EP3028692B1/en
Priority to BRPI0411361A priority patent/BRPI0411361B1/en
Priority to EP04754624A priority patent/EP1631257A2/en
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of WO2004112836A2 publication Critical patent/WO2004112836A2/en
Publication of WO2004112836A3 publication Critical patent/WO2004112836A3/en
Publication of WO2004112836A8 publication Critical patent/WO2004112836A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of two polymers that have a synergistic effect on viscosity.
PCT/US2004/018068 2003-06-13 2004-06-08 Ophthalmic compositions containing a synergistic combination of two polymers WO2004112836A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2006533590A JP4860475B2 (en) 2003-06-13 2004-06-06 Ophthalmic composition comprising a synergistic combination of two polymers
AU2004249137A AU2004249137B2 (en) 2003-06-13 2004-06-06 Ophthalmic compositions containing a synergistic combination of two polymers
CA2527712A CA2527712C (en) 2003-06-13 2004-06-06 Ophthalmic compositions containing a synergistic combination of two polymers
KR1020057023409A KR101147046B1 (en) 2003-06-13 2004-06-06 Ophthalmic compositions containing a synergistic combination of two polymers
KR1020117005797A KR101131056B1 (en) 2003-06-13 2004-06-06 Ophthalmic compositions containing a synergistic combination of two polymers
MXPA05013290A MXPA05013290A (en) 2003-06-13 2004-06-08 Ophthalmic compositions containing a synergistic combination of two polymers.
EP16153017.5A EP3028692B1 (en) 2003-06-13 2004-06-08 Ophthalmic compositions containing a synergistic combination of two polymers
BRPI0411361A BRPI0411361B1 (en) 2003-06-13 2004-06-08 ophthalmic compositions containing a synergistic combination of two polymers
EP04754624A EP1631257A2 (en) 2003-06-13 2004-06-08 Ophthalmic compositions containing a synergistic combination of two polymers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47825303P 2003-06-13 2003-06-13
US60/478,253 2003-06-13

Publications (3)

Publication Number Publication Date
WO2004112836A2 WO2004112836A2 (en) 2004-12-29
WO2004112836A3 WO2004112836A3 (en) 2005-06-16
WO2004112836A8 true WO2004112836A8 (en) 2013-02-14

Family

ID=33539082

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/018068 WO2004112836A2 (en) 2003-06-13 2004-06-08 Ophthalmic compositions containing a synergistic combination of two polymers

Country Status (16)

Country Link
US (1) US7709012B2 (en)
EP (5) EP3028692B1 (en)
JP (4) JP4860475B2 (en)
KR (5) KR101147046B1 (en)
CN (1) CN100475192C (en)
AU (2) AU2004249137B2 (en)
BR (1) BRPI0411361B1 (en)
CA (6) CA2527712C (en)
DK (1) DK2116227T3 (en)
ES (3) ES2415738T3 (en)
MX (1) MXPA05013290A (en)
PL (1) PL2116227T3 (en)
PT (1) PT2116227E (en)
SI (1) SI2116227T1 (en)
WO (1) WO2004112836A2 (en)
ZA (1) ZA200509440B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
WO2005018646A1 (en) * 2003-08-21 2005-03-03 Sucampo Ag Ophthalmic composition
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7759296B2 (en) * 2003-06-19 2010-07-20 Lubrizol Advanced Materials, Inc. Cationic polymers and fixative application therefor
EP2070518A2 (en) * 2006-07-25 2009-06-17 Osmotica Corp. Ophthalmic solutions
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
CN101605531B (en) * 2007-02-09 2012-10-10 爱尔康公司 Ophthalmic compositions containing a synergistic combination of three polymers
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
EP2172224A4 (en) 2007-06-26 2013-01-16 Wakamoto Pharma Co Ltd Aqueous composition
WO2009028674A1 (en) 2007-08-29 2009-03-05 Wakamoto Pharmaceutical Co., Ltd. Latanoprost-containing aqueous pharmaceutical composition
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
MX2010009857A (en) * 2008-03-07 2010-12-07 Sun Pharma Advanced Res Co Ltd Opthalmic composition.
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2011018800A2 (en) * 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
CN104039307A (en) * 2011-04-22 2014-09-10 爱尔康研究有限公司 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
CA2858574C (en) * 2011-12-07 2017-05-30 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
UA113434C2 (en) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Ophthalmic compositions with improved dessication protection and retention
BR112017016016B1 (en) 2015-01-26 2023-12-19 Bausch & Lomb Incorporated OPHTHALMIC SUSPENSION
WO2016205574A1 (en) * 2015-06-18 2016-12-22 Common Pharma, Inc Antimicrobial formulations
JP6132968B1 (en) * 2016-01-29 2017-05-24 参天製薬株式会社 Pharmaceutical composition containing dorzolamide, polymer and boric acid
EP3446682B1 (en) * 2016-04-22 2021-05-26 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
WO2017183714A1 (en) * 2016-04-22 2017-10-26 ロート製薬株式会社 Ophthalmic composition
WO2018033792A2 (en) 2016-08-19 2018-02-22 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
JPWO2020175525A1 (en) * 2019-02-27 2021-12-23 参天製薬株式会社 Ophthalmic composition containing diquafosol or a salt thereof, a vinyl polymer and a cellulosic polymer.

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355336A (en) 1966-08-18 1967-11-28 Du Pont Thickened water-bearing inorganic oxidizer salt explosive containing crosslinked galactomannan and polyacrylamide
NL188266C (en) 1975-07-29 1992-05-18 Merck & Co Inc PROCESS FOR THE PREPARATION OF AN ORGANIC IMPLANT.
US4039662A (en) 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
DE3440352A1 (en) 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye packing
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
FR2601385B1 (en) * 1986-07-09 1989-09-29 Sucre Rech & Dev PROCESS FOR THE PREPARATION FROM SACCHAROSIS OF A MIXTURE OF HIGH SUGAR ISOMALTOSE SUGARS BY THE ENZYMATIC ROUTE AND PRODUCTS OBTAINED
US4783488A (en) 1987-01-31 1988-11-08 Bausch & Lomb Incorporated Contact lens wetting solution
US4767463A (en) 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5368843A (en) 1988-06-08 1994-11-29 Lever Brothers Company, Division Of Conopco, Inc. Thickening system
US5204325A (en) * 1988-12-15 1993-04-20 Lindstrom Richard L Viscoelastic solution
US5075104A (en) 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
JP2808378B2 (en) * 1991-03-27 1998-10-08 武田薬品工業株式会社 Manufacturing method of aqueous suspension
DE69123248T2 (en) * 1991-03-27 1997-03-13 Senju Pharma Co METHOD FOR PRODUCING AN AQUEOUS SUSPENSION
US5460834A (en) 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
JP2787131B2 (en) * 1993-07-30 1998-08-13 千寿製薬株式会社 Aqueous suspension
CN1085106A (en) * 1993-10-27 1994-04-13 吴亮 The ophthalmologic operation visco-elastic material that has fluorescence
CA2134376C (en) * 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
ATE166227T1 (en) 1994-03-18 1998-06-15 Senju Pharma Co OPTHALMOLOGICAL PREPARATIONS CONTAINING SARPOGRELATE FOR LOWERING INTRAOCULAR PRESSURE
SE9401108D0 (en) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
US5939485A (en) 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
WO1998043643A1 (en) * 1997-04-01 1998-10-08 Toa Medicine Co., Ltd. Aqueous acyclovir solution preparations
CN1762381B (en) 1997-07-29 2012-07-11 爱尔康实验室公司 Ophthalmic compositions containing galactomannan polymers and borate
DE69826730T2 (en) 1997-07-29 2005-02-10 Alcon Laboratories, Inc., Fort Worth Conditioning solutions for the care of hard contact lenses
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
ATE289804T1 (en) * 1998-10-08 2005-03-15 Hampar L Karagoezian SYNERGISTIC ANTIMICROBIAL. DERMATOLOGICAL AND OPHTAHALMOLOGICAL PREPARATIONS CONTAINING A CHLORITE AND HYDROGEN PEROXIDE
US6174859B1 (en) * 1999-04-06 2001-01-16 J & D Sciences, Inc. Method of treatment
CA2431368C (en) * 2000-12-20 2006-08-08 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
US7084130B2 (en) * 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
AR035509A1 (en) 2000-12-21 2004-06-02 Alcon Inc SOLUTION OF IMPROVED ARTIFICIAL TEARS CONTAINING A COMBINATION OF THREE EMOLIENTS AND THE USE OF SUCH SOLUTION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
JP3455852B2 (en) * 2000-12-26 2003-10-14 株式会社オフテクス Eyewash composition
EP1347787B2 (en) * 2001-01-09 2010-09-08 Louis Johan Wagenaar Use of dexpanthenol in contact lens care compositions
JP2003137775A (en) * 2001-10-31 2003-05-14 Menicon Co Ltd Ophthalmic composition
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
JP2003183157A (en) * 2001-12-19 2003-07-03 Lion Corp Ophthalmologic composition
US20040118414A1 (en) 2002-12-20 2004-06-24 Shah Mandar V Surface modified viscoelastics for ocular surgery
AU2002360752A1 (en) 2001-12-21 2003-07-30 Alcon, Inc. Viscoelastics for ocular surgery
EP1476135A1 (en) 2002-02-22 2004-11-17 Pharmacia Corporation Ophthalmic formulation with gum system
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20050013854A1 (en) 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
US20040241151A1 (en) 2003-05-27 2004-12-02 Sca Hygiene Products Ab Polymer matrix with lactic acid producing bacteria
JP4694773B2 (en) * 2003-06-06 2011-06-08 ロート製薬株式会社 Mucosal liquid composition
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
TWM258789U (en) * 2004-06-09 2005-03-11 Ming-Hsiang Yeh Interactive toy
US20060003964A1 (en) 2004-06-30 2006-01-05 Shah Mandar V Dilution resistant viscoelastic compositions
CN101605531B (en) 2007-02-09 2012-10-10 爱尔康公司 Ophthalmic compositions containing a synergistic combination of three polymers

Also Published As

Publication number Publication date
US20040253280A1 (en) 2004-12-16
JP2007500244A (en) 2007-01-11
JP2013100360A (en) 2013-05-23
PL2116227T3 (en) 2013-08-30
CA2839928C (en) 2016-10-04
EP2361610B1 (en) 2013-04-24
JP2011026354A (en) 2011-02-10
JP4860475B2 (en) 2012-01-25
SI2116227T1 (en) 2013-07-31
KR20120062846A (en) 2012-06-14
CA2839847C (en) 2016-03-15
CA2527712A1 (en) 2004-12-29
EP2526929A8 (en) 2013-04-10
CA2839928A1 (en) 2004-12-29
US7709012B2 (en) 2010-05-04
CA2839849C (en) 2017-03-07
EP2526929B1 (en) 2016-04-06
CA2839898A1 (en) 2004-12-29
CA2839847A1 (en) 2004-12-29
KR20110032007A (en) 2011-03-29
AU2010200297B2 (en) 2012-04-26
KR101131056B1 (en) 2012-04-23
ES2410505T3 (en) 2013-07-02
EP2116227B1 (en) 2013-04-24
CA2839849A1 (en) 2004-12-29
JP2011184463A (en) 2011-09-22
KR101147046B1 (en) 2012-05-22
EP3028692B1 (en) 2020-04-22
AU2004249137B2 (en) 2010-03-11
AU2004249137A1 (en) 2004-12-29
CA2839930C (en) 2016-07-05
EP2526929A1 (en) 2012-11-28
WO2004112836A2 (en) 2004-12-29
CN1802147A (en) 2006-07-12
KR20060012024A (en) 2006-02-06
EP2116227A3 (en) 2009-12-30
CA2839898C (en) 2017-01-24
CA2839930A1 (en) 2004-12-29
ZA200509440B (en) 2007-04-25
EP2361610A1 (en) 2011-08-31
AU2010200297A1 (en) 2010-02-18
KR20110098863A (en) 2011-09-01
WO2004112836A3 (en) 2005-06-16
DK2116227T3 (en) 2013-05-27
EP2116227A2 (en) 2009-11-11
ES2415738T3 (en) 2013-07-26
EP1631257A2 (en) 2006-03-08
EP3028692A1 (en) 2016-06-08
ES2570856T3 (en) 2016-05-20
PT2116227E (en) 2013-06-28
KR20110134525A (en) 2011-12-14
BRPI0411361B1 (en) 2017-05-23
BRPI0411361A (en) 2006-07-25
CA2527712C (en) 2014-08-05
CN100475192C (en) 2009-04-08
MXPA05013290A (en) 2006-03-09

Similar Documents

Publication Publication Date Title
WO2004112836A3 (en) Ophthalmic compositions containing a synergistic combination of two polymers
WO2004112750A3 (en) Ophthalmic compositions containing a synergistic combination of three polymers
WO2008100807A3 (en) Ophthalmic compositions containing a synergistic combination of three polymers
WO2005001077A3 (en) Repair and regeneration of ocular tissue using postpartum-derived cells
WO2007010034A3 (en) Ampholytic copolymer, production thereof, and use of the same
WO2006060618A3 (en) Topical nepafenac formulations
AU2003297684A1 (en) Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
EP1626688A4 (en) System for cutting the cornea of an eye
AU2003278796A1 (en) Compositions containing at least one oil structured with at least one silicone-polyamide polymer
EP1654380A4 (en) Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
WO2006105403A3 (en) Treatment of eye disorders with sirtuin modulators
WO2007044026A3 (en) Compositions comprising modified collagen and uses therefore
WO2006127987A3 (en) Treatment of eye disorders with sirtuin modulators
WO2006034039A3 (en) Substituted morphinans and methods of their use
WO2005034650A8 (en) Weight-loss supplement
IL173807A0 (en) Amphiphilic antioxidant compounds, mitoquinone derivatives and pharmaceutical compositions containing the same
WO2005009460A3 (en) Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
AU2003299195A1 (en) Double-barrel syringe for ophthalmic surgeries
WO2003028696A3 (en) Compositions for delivery of drug combinations
WO2002053519A3 (en) Hydrophobic polyamine analogs and methods for their use
WO2006044155A3 (en) Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
EP1661573A4 (en) Ophthalmic composition
AU2002353487A1 (en) Herbal ophthalmic formulation for preventing cataract
AU2003272127A1 (en) Polymeric composition for drug delivery

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004754624

Country of ref document: EP

Ref document number: 2005/09440

Country of ref document: ZA

Ref document number: 200509440

Country of ref document: ZA

Ref document number: 2006533590

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004249137

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2527712

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020057023409

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/013290

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 20048159648

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2004249137

Country of ref document: AU

Date of ref document: 20040606

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004249137

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1020057023409

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2004754624

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0411361

Country of ref document: BR